# Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)

> **NCT00770900** · PHASE4 · COMPLETED · sponsor: **University of Brasilia** · enrollment: 83 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** montelukast sodium
- **DRUG:** Comparator: placebo comparator

## Key facts

- **NCT ID:** NCT00770900
- **Lead sponsor:** University of Brasilia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2010-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770900, "Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00770900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*